307 related articles for article (PubMed ID: 27863787)
1. Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism.
Trinh G; Noureldine SI; Russell JO; Agrawal N; Lopez M; Prescott JD; Zeiger MA; Tufano RP
Surgery; 2017 Jan; 161(1):78-86. PubMed ID: 27863787
[TBL] [Abstract][Full Text] [Related]
2. Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism.
Applewhite MK; White MG; Tseng J; Mohammed MK; Mercier F; Kaplan EL; Angelos P; Vokes T; Grogan RH
Surgery; 2017 Jan; 161(1):62-69. PubMed ID: 27866715
[TBL] [Abstract][Full Text] [Related]
3. Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.
Trinh G; Rettig E; Noureldine SI; Russell JO; Agrawal N; Mathur A; Prescott JD; Zeiger MA; Tufano RP
Otolaryngol Head Neck Surg; 2018 Oct; 159(4):630-637. PubMed ID: 30105919
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative parathyroid hormone levels ≤40 pg/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism.
Claflin J; Dhir A; Espinosa NM; Antunez AG; Cohen MS; Gauger PG; Miller BS; Hughes DT
Surgery; 2019 Jul; 166(1):50-54. PubMed ID: 30975497
[TBL] [Abstract][Full Text] [Related]
5. What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?
Wachtel H; Cerullo I; Bartlett EK; Kelz RR; Karakousis GC; Fraker DL
Ann Surg Oncol; 2015; 22(6):1781-8. PubMed ID: 25354574
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperparathyroidism with normal baseline intraoperative parathyroid hormone: A challenging population.
Javid M; Callender G; Quinn C; Carling T; Donovan P; Udelsman R
Surgery; 2017 Feb; 161(2):493-498. PubMed ID: 27712879
[TBL] [Abstract][Full Text] [Related]
7. The necessity and reliability of intraoperative parathyroid hormone (PTH) testing in patients with mild hyperparathyroidism and PTH levels in the normal range.
Alhefdhi A; Pinchot SN; Davis R; Sippel RS; Chen H
World J Surg; 2011 Sep; 35(9):2006-9. PubMed ID: 21713573
[TBL] [Abstract][Full Text] [Related]
8. Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.
Cayo AK; Sippel RS; Schaefer S; Chen H
Ann Surg Oncol; 2009 Dec; 16(12):3450-4. PubMed ID: 19760044
[TBL] [Abstract][Full Text] [Related]
9. Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.
Ahmed K; Alhefdhi A; Schneider DF; Ojomo KA; Sippel RS; Chen H; Mazeh H
Ann Surg Oncol; 2013 Dec; 20(13):4200-4. PubMed ID: 23943032
[TBL] [Abstract][Full Text] [Related]
10. Significance of rebounding parathyroid hormone levels during parathyroidectomy.
Schneider DF; Ojomo KA; Mazeh H; Oltmann SC; Sippel RS; Chen H
J Surg Res; 2013 Sep; 184(1):265-8. PubMed ID: 23669749
[TBL] [Abstract][Full Text] [Related]
11. The final intraoperative parathyroid hormone level: how low should it go?
Wharry LI; Yip L; Armstrong MJ; Virji MA; Stang MT; Carty SE; McCoy KL
World J Surg; 2014 Mar; 38(3):558-63. PubMed ID: 24253106
[TBL] [Abstract][Full Text] [Related]
12. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients.
Chiu B; Sturgeon C; Angelos P
Arch Surg; 2006 May; 141(5):483-7; discussion 487-8. PubMed ID: 16702520
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.
Dobrinja C; Santandrea G; Giacca M; Stenner E; Ruscio M; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S26-S33. PubMed ID: 28506410
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring.
Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Ito K
Endocr J; 2010; 57(11):953-8. PubMed ID: 20823623
[TBL] [Abstract][Full Text] [Related]
15. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
Heller KS; Blumberg SN
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
[TBL] [Abstract][Full Text] [Related]
16. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.
Nilubol N; Weisbrod AB; Weinstein LS; Simonds WF; Jensen RT; Phan GQ; Hughes MS; Libutti SK; Marx S; Kebebew E
World J Surg; 2013 Aug; 37(8):1966-72. PubMed ID: 23722465
[TBL] [Abstract][Full Text] [Related]
17. Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate?
Sohn JA; Oltmann SC; Schneider DF; Sippel RS; Chen H; Elfenbein DM
Am J Surg; 2015 Mar; 209(3):483-7. PubMed ID: 25556028
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative parathyroid hormone monitoring in patients with recognized multiglandular primary hyperparathyroidism.
Hughes DT; Miller BS; Doherty GM; Gauger PG
World J Surg; 2011 Feb; 35(2):336-41. PubMed ID: 21153816
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism.
Lang BH; Fung MMH
Surgery; 2021 Jan; 169(1):109-113. PubMed ID: 32402543
[TBL] [Abstract][Full Text] [Related]
20. Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism.
Shawky M; Abdel Aziz T; Morley S; Beale T; Bomanji J; Soromani C; Lam F; Philips I; Matias M; Honour J; Smart J; Kurzawinski TR
Clin Endocrinol (Oxf); 2019 Feb; 90(2):277-284. PubMed ID: 30346646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
